Significant response to apatinib monotherapy in heavily pretreated advanced HER2-positive breast cancer: a case report and literature review

Although HER2-targeted therapy has been shown to prolong the survival of patients with HER2-positive breast cancer, most patients eventually progress due to drug resistance. Novel treatment options are urgently needed to overcome resistance to HER2-targeted therapy. The VEGF/VEGFR (Vascular endothel...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Biol Ther
Main Authors: Danni, Li, Lingyun, Zhang, Jian, Wang, Hongfei, Yan, Lu, Xu, Peng, Yang, Xiujuan, Qu, Yunpeng, Liu, Yuee, Teng
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2020
Assuntos:
Bedside-to-Bench Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7515454/
https://ncbi.nlm.nih.gov/pubmed/32233990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2020.1743159
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares